Influence of hydroxyapatite pore geometry on tigecycline release kinetics
Source abstract
Abstract
Abstract Calcium hydroxyapatite (CHA), as one of the most important ceramic materials in bone tissue engineering, was used as a delivery system for tigecycline, a potential antibiotic in treatment of osteomyelitis. Tigecycline, in a solid state, was mixed with CHA powder and the obtained mixture was compressed into tablets. The release of tigecycline from these tablets in a pH 7.4 phosphate-buffered saline solution was measured by a UV–vis spectrophotometer at 37 °C. The total dose of tigecycline was released for 5 to 30 days, depending on the applied pressure and drug concentration. A new drug release mechanism that determines the relationship between pore sizes and drug release rate is proposed. It explains and quantifies the drug release kinetics based on pore sizes and pore size distribution.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (26)
Show source-provided references
1. Calcium phosphate cements as bone drug delivery systems: A review10.1016/j.jconrel.2006.04.007 ↗
2. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering10.1016/j.addr.2007.03.011 ↗
3. Controlled release of bovine serum albumin from hydroxyapatite microspheres for protein delivery system10.1016/j.mseb.2007.09.006 ↗
4. Skeletal drug delivery systems10.1016/S0378-5173(00)00468-3 ↗
5. Prosthetic joint infections: microbiology, diagnosis, management and prevention10.1016/j.ijantimicag.2008.03.010 ↗
6. Prevention of perioperative infection10.2106/JBJS.F.00901 ↗
7. The kinetics of pentoxifylline release from drug-loaded hydroxyapatite implants10.1016/S0142-9612(99)00269-0 ↗
8. Prolonged local antibiotics delivery from hydroxyapatite functionalized with cyclodextrin polymers10.1016/j.biomaterials.2009.07.045 ↗
9. Release of gentamicin from bone regenerative materials: an in vitro study10.1002/jbm.b.30631 ↗
10. N.M. Ruiz, E. Gayoso, Y. Vasquez, Tigecycline usage in osteomyelitis caused by multidrugresistent acinetobacter: A report of 10 cases from a single institution, 14th International Congress on Infectious Diseases (ICID) Abstracts, 〈10.1016/j.ijid.2010.02.1932〉10.1016/j.ijid.2010.02.1932 ↗
11. Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based?10.1016/j.ijid.2010.01.005 ↗
12. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model10.1093/jac/dki109 ↗
13. Tigecycline: A new antibiotic10.1016/j.iccn.2008.03.006 ↗
14. Calcium phosphate cements: Competitive drug carriers for the musculoskeletal system?10.1016/j.biomaterials.2005.11.023 ↗
15. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
16. Jena · 1992
17. Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release10.1016/S0142-9612(00)00082-X ↗
18. Intrinsic porosity of calcium phosphate cements and its significance for drug delivery and tissue engineering applications10.1016/j.actbio.2009.03.011 ↗
19. Porous hydroxyapatite tablets as carriers for low-dosed drugs10.1016/j.ejpb.2007.02.018 ↗
20. Ibuprofen release from porous hydroxyapatite tablets10.1016/j.ceramint.2011.02.021 ↗
21. Hydrothermal synthesis and nanostructure of carbonated calcium hydroxyapatite10.1007/s10856-006-8937-z ↗
22. Effect of geometrical cement size on in vitro and in vivo indomethacin release from self-setting apatite cement10.1016/S0168-3659(97)00264-2 ↗
23. Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes10.1016/j.biomaterials.2007.02.007 ↗
24. Study of implantable calcium phosphate systems for the slow release of methotrexate10.1016/S0142-9612(02)00082-0 ↗
25. Diffusion-Controlled Drug Delivery Systems
26. Release profile of antimicrobial agents from α-tricalcium phosphate cement10.1016/S0142-9612(00)00438-5 ↗